Advanced Search
- Home
- Content
- Current
- Ahead of print
- Past Issues
- JNM Supplement
- SNMMI Annual Meeting Abstracts
- JNM Podcasts
- Subscriptions
- Subscribers
- Institutional and Non-member
- Rates
- Journal Claims
- Authors
- Submit to JNM
- Information for Authors
- Assignment of Copyright
- AQARA requirements
- Info
- Reviewers
- Permissions
- Advertisers
- About
- About Us
- Editorial Board
- Contact Information
- More
- Alerts
- Feedback
- Help
- SNMMI Journals
- View or Listen to JNM Podcast
- Visit JNM on Facebook
- Join JNM on LinkedIn
- Follow JNM on Twitter
- Subscribe to our RSS feeds
October 24, 2024
Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
Adriana Amerein, Christoph Maurer, Malte Kircher, Alexander Gäble, Anne Krebold, Andreas Rinscheid, Oliver Viering, Christian H. Pfob, Ralph A. Bundschuh, Lars Behrens, Arthur JAT Braat, Ansgar Berlis and Constantin Lapa
Journal of Nuclear Medicine October 24, 2024, jnumed.124.268217; DOI: https://doi.org/10.2967/jnumed.124.268217
Head-to-Head Comparison of [68Ga]Ga-NOTA-RM26 and [18F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study
Rongxi Wang, Weiming Kang, Zhen Liu, Yumin Zheng, Huimin Sui, Linlin Li, Jiarou Wang, Jialin Xiang, Xingtong Peng, Xiaoyuan Chen, Zhaohui Zhu and Jingjing Zhang
Journal of Nuclear Medicine October 24, 2024, jnumed.124.267810; DOI: https://doi.org/10.2967/jnumed.124.267810
Modeling PET Data Acquired During Nonsteady Conditions: What If Brain Conditions Change During the Scan?
Evan D. Morris, Gaelle M. Emvalomenos, Jocelyn Hoye and Steven R. Meikle
Journal of Nuclear Medicine October 24, 2024, jnumed.124.267494; DOI: https://doi.org/10.2967/jnumed.124.267494
MIRD Pamphlet No. 31: MIRDcell V4—Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy
Sumudu Katugampola, Jianchao Wang and Roger W. Howell
Journal of Nuclear Medicine October 24, 2024, jnumed.123.267238; DOI: https://doi.org/10.2967/jnumed.123.267238
[18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy
Jelena Levi, Millie Das, Minal S. Vasanawala, Deepti Behl, Martin Pomper, Patrick M. Forde, Erica Nakajima, James Sayre, Bin Shen, Hilda Cabrera, Niko Del Mar, Michele Gullen, Michele Pierini, Laura Cox, Ojaswita Lokre, Timothy Perk and Hee-Don Chae
Journal of Nuclear Medicine October 24, 2024, jnumed.124.268253; DOI: https://doi.org/10.2967/jnumed.124.268253
October 17, 2024
Open Access
Improved Localization of Insulinomas Using 68Ga-NODAGA-Exendin-4 PET/CT
Marti Boss, Olof Eriksson, Kirsi Mikkola, Annemarie Eek, Maarten Brom, Mijke Buitinga, Adrienne H. Brouwers, Irina Velikyan, Beatrice Waser, Saila Kauhanen, Olof Solin, Camille Marciniak, Barbro Eriksson, Jean-Claude Reubi, Cyrielle Aveline, Damian Wild, Francois Pattou, Jean-Noel Talbot, Johannes Hofland, Anders Sundin, Pirjo Nuutila, John Hermans and Martin Gotthardt
Journal of Nuclear Medicine October 17, 2024, jnumed.124.268158; DOI: https://doi.org/10.2967/jnumed.124.268158
One Bite from the Apple, One Bite from the Orange in the PRECISE-MDT Study
Andrei Fodor, Cristiano Pini, Gaia Ninatti, Nadia Di Muzio and Arturo Chiti
Journal of Nuclear Medicine October 17, 2024, jnumed.124.268395; DOI: https://doi.org/10.2967/jnumed.124.268395
Limitations of Retrospective Study Design and Potential Bias in the PRECISE-MDT Study
Tadashi Watabe
Journal of Nuclear Medicine October 17, 2024, jnumed.124.268447; DOI: https://doi.org/10.2967/jnumed.124.268447
Reply: One Bite from the Apple, One Bite from the Orange in the PRECISE-MDT Study and Limitations of Retrospective Study Design and Potential Bias in the PRECISE-MDT Study
Matteo Bauckneht, Francesco Lanfranchi and Liliana Belgioia
Journal of Nuclear Medicine October 17, 2024, jnumed.124.268781; DOI: https://doi.org/10.2967/jnumed.124.268781
Open Access
SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0
Javier Arbizu, Silvia Morbelli, Satoshi Minoshima, Henryk Barthel, Philip Kuo, Donatienne Van Weehaeghe, Neil Horner, Patrick M. Colletti and Eric Guedj
Journal of Nuclear Medicine October 17, 2024, jnumed.124.268754; DOI: https://doi.org/10.2967/jnumed.124.268754
October 10, 2024
Open Access
uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence
Edwin C. Pratt, Riccardo Mezzadra, Amanda Kulick, Spencer Kaminsky, Zachary V. Samuels, Angelique Loor, Elisa de Stanchina, Scott W. Lowe and Jason S. Lewis
Journal of Nuclear Medicine October 10, 2024, jnumed.124.268278; DOI: https://doi.org/10.2967/jnumed.124.268278
Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands
Nathalie L. Albert, Matthias Preusser, Norbert Galldiks and Jana Ivanidze
Journal of Nuclear Medicine October 10, 2024, jnumed.124.268314; DOI: https://doi.org/10.2967/jnumed.124.268314
Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer
Qiufang Liu, Xiaoping Xu, Ziyi Yang, Jianping Zhang, Jindian Li, Ying Qiao, Silong Hu, Xiaosheng Liu, Weijian Guo and Shaoli Song
Journal of Nuclear Medicine October 10, 2024, jnumed.124.267529; DOI: https://doi.org/10.2967/jnumed.124.267529
Diagnostic Radiopharmaceuticals: A Sustainable Path to the Improvement of Patient Care
Andrei Gafita, Andrew R. Menard and Lilja B. Solnes
Journal of Nuclear Medicine October 10, 2024, jnumed.124.268608; DOI: https://doi.org/10.2967/jnumed.124.268608
Impact of 18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial
Kai Jannusch, Lale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, Janna Morawitz, Ken Herrmann, Wolfgang Peter Fendler, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhäberle, Martin Stuschke, Werner Schmid, Frederik Giesel, Lena Häberle, Irene Esposito, Wilfried Budach, Johannes Grueneisen, Christiane Matuschek, Bernd Kowall, Andreas Stang, Gerald Antoch and Christian Buchbender
Journal of Nuclear Medicine October 10, 2024, jnumed.124.268065; DOI: https://doi.org/10.2967/jnumed.124.268065
October 3, 2024
Cardiac Neuroendocrine Tumor Metastases on 68Ga-DOTATATE PET/CT: Identification and Prognostic Significance
Hwan Lee, Ahmad S. Alhamshari, Vandan Patel, Abhijit Bhattaru, Chaitanya Rojulpote, Mahesh K. Vidula, Daniel A. Pryma and Paco E. Bravo
Journal of Nuclear Medicine October 3, 2024, jnumed.124.267948; DOI: https://doi.org/10.2967/jnumed.124.267948
Open Access
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
Jeremie Calais, Michael J. Morris, Ayse Tuba Kendi, Arash Rezazadeh Kalebasty, Ronald Tutrone, Michael J. Anderson and Oliver Sartor
Journal of Nuclear Medicine October 3, 2024, jnumed.124.268363; DOI: https://doi.org/10.2967/jnumed.124.268363
Impact of 18F-FES PET/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast Cancer
Jeongryul Ryu, Jaewon Hyung, Sangwon Han, Jae Ho Jeong, Sae Byul Lee, Tae-Kyung Robyn Yoo, Jisun Kim, Hee Jeong Kim, Il Yong Chung, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Hyehyun Jeong, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim and Dae Hyuk Moon
Journal of Nuclear Medicine October 3, 2024, jnumed.124.267913; DOI: https://doi.org/10.2967/jnumed.124.267913
The Updated Registry of Fast Myocardial Perfusion Imaging with Next-Generation SPECT (REFINE SPECT 2.0)
Robert J.H. Miller, Mark Lemley, Aakash Shanbhag, Giselle Ramirez, Joanna X. Liang, Valerie Builoff, Paul Kavanagh, Tali Sharir, M. Timothy Hauser, Terrence D. Ruddy, Mathews B. Fish, Timothy M. Bateman, Wanda Acampa, Andrew J. Einstein, Sharmila Dorbala, Marcelo F. Di Carli, Attila Feher, Edward J. Miller, Albert J. Sinusas, Julian Halcox, Monica Martins, Philipp A. Kaufmann, Damini Dey, Daniel S. Berman and Piotr J. Slomka
Journal of Nuclear Medicine October 3, 2024, jnumed.124.268292; DOI: https://doi.org/10.2967/jnumed.124.268292
Preclinical Evaluation of 226Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy
Helena Koniar, Luke Wharton, Aidan Ingham, Ana Paulina Morales Oliver, Helen Merkens, Cristina Rodríguez-Rodríguez, Peter Kunz, Valery Radchenko, Hua Yang, Arman Rahmim, Carlos Uribe and Paul Schaffer
Journal of Nuclear Medicine October 3, 2024, jnumed.124.267999; DOI: https://doi.org/10.2967/jnumed.124.267999
Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
Masatoshi Hotta, Grace Hyun J. Kim, Vilasinee Rerkpichaisuth, Pang Yu Teng, Wesley R. Armstrong, Giuseppe Carlucci, Magnus Dahlbom, Fereidoun Abtin, Shahrzad M. Lari, Gregory A. Fishbein, Johannes Czernin, Elizabeth R. Volkmann, S. Sam Weigt and Jeremie Calais
Journal of Nuclear Medicine October 3, 2024, jnumed.124.268351; DOI: https://doi.org/10.2967/jnumed.124.268351
Routine Use of [64Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans
Esben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, Ulrich Knigge, Seppo W. Langer, Jann Mortensen, Lotte Enevoldsen, Peter Oturai and Andreas Kjaer
Journal of Nuclear Medicine October 3, 2024, jnumed.124.267939; DOI: https://doi.org/10.2967/jnumed.124.267939
U.S. Imaging Costs
Michal Horný, Ken Herrmann and Johannes Czernin
Journal of Nuclear Medicine October 3, 2024, jnumed.124.268825; DOI: https://doi.org/10.2967/jnumed.124.268825
Open Access
The Role of Molecular Imaging in Precision Oncology
James R. Bading and Joanne E. Mortimer
Journal of Nuclear Medicine October 3, 2024, jnumed.124.268036; DOI: https://doi.org/10.2967/jnumed.124.268036
Arrhythmias in Nongranulomatous Myocarditis: Is There a Role for PET?
Matthieu Pelletier-Galarneau, François Simard, Rafik Tadros and Maxime Tremblay-Gravel
Journal of Nuclear Medicine October 3, 2024, jnumed.124.268033; DOI: https://doi.org/10.2967/jnumed.124.268033
Association of Free-to-Total PSA Ratio and 18F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study
Rui M. Bernardino, Katherine Lajkosz, Leyi B. Yin, Rashid K. Sayyid, Marian Wettstein, Harkanwal Randhawa, Jessica G. Cockburn, Sayeed Ahmed, Rosita Thomassian, Eleftherios Diamandis, Ur Metser, Alejandro Berlin and Neil E. Fleshner
Journal of Nuclear Medicine October 3, 2024, jnumed.124.267877; DOI: https://doi.org/10.2967/jnumed.124.267877
Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma
Maria C. Ferrández, Sandeep S.V. Golla, Jakoba J. Eertink, Sanne E. Wiegers, Gerben J.C. Zwezerijnen, Martijn W. Heymans, Pieternella J. Lugtenburg, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Sally F. Barrington, N. George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sándor Czibor, Tamás Györke, Martine E.D. Chamuleau, Josée M. Zijlstra and Ronald Boellaard; on behalf of the PETRA Consortium
Journal of Nuclear Medicine October 3, 2024, jnumed.124.268191; DOI: https://doi.org/10.2967/jnumed.124.268191
Freehand SPECT Combined with 3-Dimensional Light Detection and Ranging as Alternative Means of Specimen Scanning During Prostate Cancer Surgery
Giusi Pisano, Matthias N. van Oosterom, Anne-Claire Berrens, Leon J. Slof, Daphne D.D. Rietbergen, Henk G. van der Poel, Pim J. van Leeuwen and Fijs W.B. van Leeuwen
Journal of Nuclear Medicine October 3, 2024, jnumed.124.268256; DOI: https://doi.org/10.2967/jnumed.124.268256
September 26, 2024
[18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
Yinjun Dong, Zhendan Wang, Xinying Hu, Yuhong Sun, Jingjie Qin, Qiming Qin, Shuguang Liu, Shuanghu Yuan, Jinming Yu and Yuchun Wei
Journal of Nuclear Medicine September 26, 2024, jnumed.124.268557; DOI: https://doi.org/10.2967/jnumed.124.268557
Summary: Appropriate Use Criteria for the Use of Nuclear Medicine in Fever of Unknown Origin
Christopher J. Palestro, Gad Abikhzer, Zvi Bar-Sever, Twyla Bartel, Rebecca Brady, Erin E. Grady, Ora Israel, Sanjay K. Jain, Sheetal Kandiah, Machaba M. Sathekge and Barry L. Shulkin
Journal of Nuclear Medicine September 26, 2024, jnumed.124.268797; DOI: https://doi.org/10.2967/jnumed.124.268797
Open Access
Preclinical Investigation of [212Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model
Amal Saidi, Tania A. Stallons, Amy G. Wong and Julien J. Torgue
Journal of Nuclear Medicine September 26, 2024, jnumed.124.268101; DOI: https://doi.org/10.2967/jnumed.124.268101
Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery
Lilit Schweiger, Tobias Maurer, Ricarda Simon, Thomas Horn, Matthias Heck, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
Journal of Nuclear Medicine September 26, 2024, jnumed.124.268151; DOI: https://doi.org/10.2967/jnumed.124.268151
Evaluation of Fibroblast Activation Protein Expression Using 68Ga-FAPI46 PET in Hypertension-Induced Tissue Changes
Jung Woo Byun, Jin Chul Paeng, Young Ju Kim, Seung-Pyo Lee, Yun-Sang Lee, Hongyoon Choi, Keon Wook Kang and Gi Jeong Cheon
Journal of Nuclear Medicine September 26, 2024, jnumed.124.267489; DOI: https://doi.org/10.2967/jnumed.124.267489
Open Access
Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
Frédéric Pouliot, Fred Saad, Etienne Rousseau, Patrick O. Richard, Atefeh Zamanian, Stephan Probst, Éric Lévesque, Vincent Castonguay, Nicolas Marcoux, Michele Lodde, Daniel Juneau, Zineb Hamilou, Jean-Baptiste Lattouf, François-Alexandre Buteau, Michel Pavic, Jean-François Castilloux, Bertrand Neveu, Guillaume F. Bouvet, Catherine Allard, Amélie Tétu, Brigitte Guérin, Jean-Mathieu Beauregard and for the 3TMPO Investigators
Journal of Nuclear Medicine September 26, 2024, jnumed.124.268020; DOI: https://doi.org/10.2967/jnumed.124.268020
Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
Vishnu Murthy, Andrew F. Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, Sydney Caputo, Elisa Ledet, Abraham Akerele, Abuzar Moradi Tuchayi, Courtney Lawhn-Heath, Tingchang Wang, Michael A. Carducci, Martin G. Pomper, Channing J. Paller, Johannes Czernin, Lilja B. Solnes, Thomas A. Hope, Oliver Sartor, Jeremie Calais and Andrei Gafita
Journal of Nuclear Medicine September 26, 2024, jnumed.124.267816; DOI: https://doi.org/10.2967/jnumed.124.267816
MIRD Pamphlet No. 30: MIRDfit—A Tool for Fitting of Biodistribution Time–Activity Data for Internal Dosimetry
Lukas M. Carter, Juan Camilo Ocampo Ramos, Seval Beykan Schuerrle, Harry Marquis, Michael Lassmann, Wesley E. Bolch and Adam L. Kesner
Journal of Nuclear Medicine September 26, 2024, jnumed.124.268011; DOI: https://doi.org/10.2967/jnumed.124.268011
September 19, 2024
Reimagining Biologically Adapted Somatostatin Receptor–Targeted Radionuclide Therapy: Perspectives Based on Personal Experience and Observations on Recent Trials
David Taïeb, Desirée Deandreis and Rodney J. Hicks
Journal of Nuclear Medicine September 19, 2024, jnumed.124.268136; DOI: https://doi.org/10.2967/jnumed.124.268136
Is the Clinical Application of CXCR4 Imaging in the Diagnosis and Management of Primary Aldosteronism Really Happening?
Xiang Li, Jie Ding, Stefanie Hahner, Martin Reincke, Marcus Hacker, Constantin Lapa and Li Huo
Journal of Nuclear Medicine September 19, 2024, jnumed.124.268145; DOI: https://doi.org/10.2967/jnumed.124.268145
Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction
Andrei Gafita, Andrew Voter, Somya Shesadri, Avery Spitz, Catherine H. Marshall, Steven P. Rowe, Mark C. Markwoski, Martin G. Pomper, A. Cahid Civelek, Michael A. Carducci, Samuel R. Denmeade, Jeffrey Young, Kenneth J. Pienta, Channing J. Paller and Lilja B. Solnes
Journal of Nuclear Medicine September 19, 2024, jnumed.124.267723; DOI: https://doi.org/10.2967/jnumed.124.267723
Challenges with 177Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice
Hossein Jadvar, Amir Iravani, Lisa Bodei and Jeremie Calais
Journal of Nuclear Medicine September 19, 2024, jnumed.124.268023; DOI: https://doi.org/10.2967/jnumed.124.268023
Open Access
Validation of a Simplified Tissue-to-Reference Ratio Measurement Using SUVR to Assess Synaptic Density Alterations in Alzheimer Disease with [11C]UCB-J PET
Juan J. Young, Ryan S. O’Dell, Mika Naganawa, Takuya Toyonaga, Ming-Kai Chen, Nabeel B. Nabulsi, Yiyun Huang, Emma Cooper, Alyssa Miller, Jessica Lam, Kara Bates, Audrey Ruan, Kimberly Nelsen, Elaheh Salardini, Richard E. Carson, Christopher H. van Dyck and Adam P. Mecca
Journal of Nuclear Medicine September 19, 2024, jnumed.124.267419; DOI: https://doi.org/10.2967/jnumed.124.267419
September 5, 2024
First-in-Human Total-Body PET/CT Imaging Using 89Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma
Harshad R. Kulkarni, Kevin A. Maupin, Tina Brennan, Jens Forsberg, Dan Rogers, Mark Olson, Brandon R. Mancini, Anthony Chang, Sreenivasa R. Chandana and Ryohei Kobayashi
Journal of Nuclear Medicine September 5, 2024, jnumed.124.268074; DOI: https://doi.org/10.2967/jnumed.124.268074
The Translation of Dosimetry into Clinical Practice: What It Takes to Make Dosimetry a Mandatory Part of Clinical Practice
Manuel Bardiès, Glenn Flux and Katarina Sjögreen Gleisner
Journal of Nuclear Medicine September 5, 2024, jnumed.124.267742; DOI: https://doi.org/10.2967/jnumed.124.267742
August 14, 2024
The Costs to Our Patients
Michael G. Stabin
Journal of Nuclear Medicine August 14, 2024, jnumed.124.268290; DOI: https://doi.org/10.2967/jnumed.124.268290
July 8, 2021
The Annual Journal Impact Factor Saga
Johannes Czernin
Journal of Nuclear Medicine July 8, 2021, jnumed.121.262860; DOI: https://doi.org/10.2967/jnumed.121.262860
April 23, 2021
The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Ruohua Chen, Yining Wang, Yinjie Zhu, Yiping Shi, Lian Xu, Gang Huang and Jianjun Liu
Journal of Nuclear Medicine April 23, 2021, jnumed.121.262250; DOI: https://doi.org/10.2967/jnumed.121.262250
November 13, 2020
Humana and 18F-FDG PET/CT: Another Sequel to the Injustice of Being Judged by the Errors of Others
Johannes Czernin and Andrei Iagaru
Journal of Nuclear Medicine November 13, 2020, jnumed.120.260208; DOI: https://doi.org/10.2967/jnumed.120.260208
June 8, 2020
Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging
Venkatesh Locharla Murthy, Timothy M. Bateman, Wengen Chen, Saurabh Malhotra, Edward Miller, Terrence Ruddy and Vasken Dilsizian
Journal of Nuclear Medicine June 8, 2020, jnumed.120.245399; DOI: https://doi.org/10.2967/jnumed.120.245399
May 15, 2020
Open Access
Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI
Hicham Skali, Venkatesh L. Murthy, Mouaz H. Al-Mallah, Tim M. Bateman, Rob Beanlands, Nathan Better, Dennis A. Calnon, Vasken Dilsizian, Alessia Gimelli, Robert Pagnanelli, Donna M. Polk, Prem Soman, Randall C. Thompson, Andrew J. Einstein and Sharmila Dorbala
Journal of Nuclear Medicine May 15, 2020, jnumed.120.246686; DOI: https://doi.org/10.2967/jnumed.120.246686
May 1, 2020
Editor's Page: Unacceptable Denials
Johannes Czernin and Martin Allen-Auerbach
Journal of Nuclear Medicine May 1, 2020, jnumed.120.248534; DOI: https://doi.org/10.2967/jnumed.120.248534
Pages
- Next
- 1
- 2